| 252.75 Data as of May 17 | -2.30 / -0.90%Today’s Change | 154.90 Today|||52-Week Range 257.35 | +26.38% Year-to-Date |
| Good News for Roche's Tarceva - Analyst Blog May 16 / Zacks.com | Nektar Posts Wider Loss, Maintains View - Analyst Blog May 15 / Zacks.com |
| Pipeline Progress at Gilead - Analyst Blog May 16 / Zacks.com | Lilly Scraps Oncology Candidate - Analyst Blog May 13 / Zacks.com |
| ASCO '13 Preview: New 'Anti-PD-1' Therapies Shrink Tumors May 15 / TheStreet.com | PDL BioPharma Misses Earnings Ests - Analyst Blog May 13 / Zacks.com |
| ASCO '13 Preview: Roche's Next-Gen Rituxan Steps Up May 15 / TheStreet.com | Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog May 08 / Zacks.com |